PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-356

  1. 821 Posts.
    lightbulb Created with Sketch. 328
    I shot them one as I think they need to remmeber to communicate and be transarent with shareholders and not treat us like mushrooms.
    The Capital raising released under the guise of FDA minutes with no explaintion as to why it was done this way is still BS IMHO.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.